Detalles de la búsqueda
1.
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
J Am Acad Dermatol
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653344
2.
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.
Allergy
; 75(1): 116-126, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31593343
3.
The effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis (ABC trial): study protocol for a pragmatic randomized controlled trial.
Trials
; 22(1): 902, 2021 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34895292
Resultados
1 -
3
de 3
1
Próxima >
>>